NYSE:CHE - Chemed Stock Price, Forecast & News

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Chemed declared a quarterly dividend on Friday, November 1st. Shareholders of record on Monday, November 11th will be paid a dividend of $0.32 per share on Monday, December 2nd. This represents a $1.28 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date is Thursday, November 7th. View Chemed's Dividend History.

Chemed declared that its Board of Directors has authorized a stock buyback program on Wednesday, March 7th 2018, which permits the company to buyback $150,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company's leadership believes its stock is undervalued.

Chemed Co. (NYSE:CHE) released its earnings results on Tuesday, October, 29th. The company reported $3.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $3.31 by $0.15. The firm earned $480.61 million during the quarter, compared to the consensus estimate of $478.89 million. Chemed had a return on equity of 35.06% and a net margin of 11.14%. Chemed's revenue was up 8.2% on a year-over-year basis. During the same quarter last year, the firm earned $3.07 earnings per share. View Chemed's Earnings History.

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Chemed.

4 brokers have issued 12 month price objectives for Chemed's stock. Their forecasts range from $405.00 to $500.00. On average, they anticipate Chemed's stock price to reach $466.25 in the next twelve months. This suggests that the stock has a possible downside of 1.6%. View Analyst Price Targets for Chemed.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.

Media stories about CHE stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemed earned a media sentiment score of 0.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Chemed.

Chemed saw a decrease in short interest in the month of December. As of December 13th, there was short interest totalling 211,300 shares, a decrease of 18.0% from the November 28th total of 257,700 shares. Based on an average daily trading volume, of 89,500 shares, the short-interest ratio is presently 2.4 days. Currently, 1.4% of the company's stock are short sold. View Chemed's Current Options Chain.

Some companies that are related to Chemed include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), BioScrip (BIOS), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include Home Depot (HD), CVS Health (CVS), Chevron (CVX), Walt Disney (DIS), Altria Group (MO), Boeing (BA), BlackRock (BLK), AT&T (T), UnitedHealth Group (UNH) and Comcast (CMCSA).

Chemed's stock is owned by a number of of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (2.29%), Boston Trust Walden Corp (0.75%), TSP Capital Management Group LLC (0.13%), Nisa Investment Advisors LLC (0.07%), Hanson & Doremus Investment Management (0.03%) and Louisiana State Employees Retirement System (0.02%). Company insiders that own Chemed stock include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Institutional Ownership Trends for Chemed.

CHE stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Nisa Investment Advisors LLC, State of Alaska Department of Revenue, Hanson & Doremus Investment Management, TrimTabs Asset Management LLC, TSP Capital Management Group LLC, IFP Advisors Inc and We Are One Seven LLC. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Insider Buying and Selling for Chemed.

CHE stock was purchased by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, AE Wealth Management LLC, Calamos Advisors LLC, Private Trust Co. NA, First Hawaiian Bank, Louisiana State Employees Retirement System and Delta Capital Management LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CHE stock can currently be purchased for approximately $473.83.

Chemed has a market capitalization of $7.59 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.

The official website for Chemed is http://www.chemed.com/.

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.